These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29957967)

  • 1. The Incidence and Frequency of Various Causes of Angioedema in Emergency Medicine.
    Karadža-Lapić L; Pikivaca T; Pervan P; Jović Zlatović J; Delin S; Prkačin I
    Acta Med Acad; 2018 May; 47(1):11-17. PubMed ID: 29957967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonallergic angioedema: role of bradykinin.
    Bas M; Adams V; Suvorava T; Niehues T; Hoffmann TK; Kojda G
    Allergy; 2007 Aug; 62(8):842-56. PubMed ID: 17620062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibitor-mediated angioedema.
    Montinaro V; Cicardi M
    Int Immunopharmacol; 2020 Jan; 78():106081. PubMed ID: 31835086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies.
    Aygören-Pürsün E; Magerl M; Maetzel A; Maurer M
    Orphanet J Rare Dis; 2018 May; 13(1):73. PubMed ID: 29728119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angioedema: etiology, pathophysiology, current and emerging therapies.
    Lewis LM
    J Emerg Med; 2013 Nov; 45(5):789-96. PubMed ID: 23992848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin].
    Muller Y; Harr T
    Rev Med Suisse; 2016 Jan; 12(500):11-2. PubMed ID: 26946694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanofiltrated C1-esterase-inhibitor in the prophylactic treatment of bradykinin-mediated angioedema.
    Greve J; Hahn J; Nordmann M; Schuler PJ; Bas M; Hoffmann TK; Hajdu Z; Buchberger M; Strassen U
    Transfusion; 2016 May; 56(5):1022-9. PubMed ID: 26756974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinin-mediated diseases.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ABC of the Warning Signs of Hereditary Angioedema.
    Grumach AS; Ferraroni N; Olivares MM; López-Serrano MC; Bygum A
    Int Arch Allergy Immunol; 2017; 174(1):1-6. PubMed ID: 28950264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
    Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
    Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hereditary angioedema due to C1-esterase inhibitor deficiency : novel approaches].
    Stehlin F; Ribi C
    Rev Med Suisse; 2020 Apr; 16(689):675-678. PubMed ID: 32270933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition and Differential Diagnosis of Hereditary Angioedema in the Emergency Department.
    Pines JM; Poarch K; Hughes S
    J Emerg Med; 2021 Jan; 60(1):35-43. PubMed ID: 33218838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
    Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
    Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world cohort study of adult and pediatric patients treated for hereditary angioedema in the United States.
    Tachdjian R; Johnson KE; Casso D; Oliveria SA; Devercelli G; Jain G
    Allergy Asthma Proc; 2020 May; 41(3):172-182. PubMed ID: 32375961
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on therapeutic developments for hereditary angioedema.
    Christiansen SC; Zuraw BL
    Allergy Asthma Proc; 2009; 30(5):500-5. PubMed ID: 19843404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
    Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
    J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Emergency management of acute angioedema].
    Bas M; Greve J; Bier H; Knopf A; Stark T; Schuler P; Hoffmann TK; Kojda G
    Dtsch Med Wochenschr; 2010 May; 135(20):1027-31. PubMed ID: 20461661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-Label Use of Agents for Management of Serious or Life-threatening Angiotensin Converting Enzyme Inhibitor-Induced Angioedema.
    Culley CM; DiBridge JN; Wilson GL
    Ann Pharmacother; 2016 Jan; 50(1):47-59. PubMed ID: 26416949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bradykinin mediated angioedema].
    Bouillet L; Boccon-Gibod I; Massot C
    Rev Med Interne; 2011 Apr; 32(4):225-31. PubMed ID: 20538389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
    Riedl M
    Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.